111

YI · NASDAQ

$3.13−$0.005 (−0.16%)TodayMarket closed ·
Prev close $3.14

About YI

111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.

Employees
1,063
Headquarters
Shanghai, Shanghai
Listed
Sep 12, 2018
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail

Leadership

111 executives
NameTitleSince
Junling Liu—2015
Gang Yu—2015
Yang Chen—2019
Jun Luo——
Jian Sun——
Nee Chuan Teo——

Revenue by product and region

Fiscal year ended Dec 31, 2024: $14.40B total revenue

By product

  • Product [Member]$14.29B99.3%
  • Service [Member]$106.51M0.7%

Similar companies

Companies in the same industry as 111

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.